#KSGO2024 is coming! Pre-registration is until April 14 📆 Hope to see you in #Busan

JGO editors met in KSGO! See you all next time 🌊🌊💙 KSGO

#TORPEDO- early outcomes in Journal of Gynecologic Oncology PFS (primary end-pt) data are now mature- will be presented later this year 🤞 ✅Primary end-pt achieved !! What's next? Multi-centre, multi-region validation 🔪 variations +path data 🚫NOT FOR ROUTINE CARE YET ejgo.org/DOIx.php?id=10…

Our new paper (regarding EPM2AIP1) is just out !! Unveiling pembrolizumab effectiveness in diverse subtypes of MSI-high endometrial cancers DOI: 10.3802/jgo.2024.35.e103 ejgo.org/DOIx.php?id=10… Journal of Gynecologic Oncology

🌟 Honoring Excellence! 🌟 At #KSGO2024, we awarded honorary memberships to Drs. Takayuki Enomoto & Mikio Mikami during our Presidential Dinner. Their dedication to #GynecologicOncology inspires us all. Congratulations to these trailblazers! 🏅

🚨 1st ASGO&ESGO joint webinar 1) ESGO new guideline for the AYA GYN cancer patients 2) Impact of Fertility Preservation on Ovarian Cancer : Clinical Analysis and Current Understandings in Asia Date and time June 20, 2024 (Thursday) at 19:00 KST 🔗 us06web.zoom.us/meeting/regist…

🫧 Cadavar workshop with Prof. Hiroyuki Kanao learning radical hysterectomy

Our new paper is just out!! HER2-negative or low expression as an unfavorable prognostic factor in patients with stage I/II uterine carcinosarcoma ejgo.org/DOIx.php?id=10… Journal of Gynecologic Oncology

✅Protocol for ROSELLA 🌹: a phase 3 study of relacorilant in combination with nab-paclitaxel versus nab-paclitaxel monotherapy in advanced platinum-resistant ovarian cancer 🔗URL: doi.org/10.3802/jgo.20…

🚨Editor's choice for July 2024 Journal of Gynecologic Oncology 📷A group that underwent lymphadenectomy had a survival advantage in serous histology compared to the group without lymphadenectomy. link: doi.org/10.3802/jgo.20…

🎙️Discover the JGO (Journal of Gynecologic Oncology) #Podcast, where we bring you the latest #research and breakthroughs in #GynecologicOncology. Search for "JGO" on #Spotify or #ApplePodcast!🎧 Journal of Gynecologic Oncology

🚨Editor's choice Phase II study of Niraparib in Japanese patients with heavily pretreated, HRD ovarian cancer: 20 patients were enrolled Confirmed ORR was 60.0% ejgo.org/DOIx.php?id=10…

🌏The Asian Society of Gynecologic Oncology (#ASGO) 2024 Meeting kicks off today in beautiful #Bali! 🇮🇩 We celebrate this gathering of brilliant minds in #GynecologicOncology and wish all participants an inspiring and fruitful time. 🌟 🔗asgo2024bali.org #ASGO2024 #Bali

🎙️ Stay updated on the latest in #GynecologicOncology with the Journal of Gynecologic Oncology (Journal of Gynecologic Oncology) #Podcast! Tune in for cutting-edge #research, and insights from global leaders in the field. 🎧 🔗 Follow now: creators.spotify.com/pod/show/ejgo #JGO #MedicalPodcast #Oncology

🎙️New #JGO #Podcast Episode! Discover how the gut #microbiome influences #PARP inhibitor efficacy in #OvarianCancer treatment. 🦠 Learn about #Phascolarctobacterium and its role in personalized therapy. 🔗 Listen now: podcasters.spotify.com/pod/show/ejgo #JGO #GynecologicOncology

🎙️New episode of the #JGOPodcast is out! Dive into the #KEYNOTE-826 East Asia subgroup analysis led by Dr. Yong-Man Kim, #pembrolizumab + chemo shows strong survival benefits in #CervicalCancer. 🔗tinyurl.com/37j9pc57 Listen now on Spotify & Apple: #JGOPodcast #oncology

#KSGO2025 Pre-congress workshop

🔊New on the JGO Podcast Does every patient with high-risk chemorefractory or relapsed #choriocarcinoma need #surgery after complete remission with #antiPD1 therapy? This study says—maybe not. 🎧tinyurl.com/cp4ay39y #Immunotherapy #GTN #JGOPodcast

Following trastuzumab deruxtecan approval, HER2 IHC 3+ testing across 65,000 solid tumors demonstrates varied prevalence. ja.ma/4elKj10

🚨Save the Date🚨 대한부인종양학회 제30차 추계 심포지엄 📅 2025년 10월 17일(금) 📍 호텔 인터불고 대구 사전등록 마감 👉 10월 10일(금)까지! sgo.or.kr/html/?pmode=in…